FDA Approves Unknown Drug — SHUANGCHENG
SHUANGCHENG has received FDA approval for ANDA 219973, marking a strategic entry into the U.S. market and solidifying the company's ability to generate immediate revenue through market distribution.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day